EnovisENOV +12.28%60 Buyback Yield % is -0.12 as of Jul. 04, 2026. GuruFocus rates ENOV with a GF Score™ of 60/100 and a GF Value™ of $49.62 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Enovis ranks better than 53.89% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Enovis's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENOV vs INSP, PRCT, AHCO: Buyback Yield % Comparison
For the Medical Devices subindustry, Enovis's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enovis Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Enovis's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enovis (ENOV) has a Buyback Yield % of -0.12 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enovis and its competitors. According to the industry distribution chart, Enovis ranks #160 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 46.1%.
Is Enovis' Buyback Yield % too high?
Enovis' current Buyback Yield % is -0.12. Based on the distribution chart, Enovis ranks #160 out of 347 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Enovis has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Buyback Yield % compare to INSP and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Enovis ranks #160 out of 347 companies for Buyback Yield %. This puts Enovis in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enovis and its competitors. Enovis's current Buyback Yield % is -0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.62, compared to a current price of $22.50 — trading 54.7% below its estimated fair value. The current Buyback Yield % is -0.12. Enovis' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Enovis (ENOV), the current Buyback Yield % is -0.12 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Enovis (ENOV) Overvalued in 2026?
Based on GuruFocus' analysis, Enovis stock appears to be undervalued.
The current stock price of $22.50 is trading 54.7% below its estimated GF Value™ of $49.62.
GuruFocus considers Enovis to be Possible Value Trap.
Key valuation signals for ENOV:
Buyback Yield %: -0.12
GF Value™: $49.62 vs. price of $22.50 (54.7% below fair value)
No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
60GF Score
Get the complete analysis for ENOV
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENOV has been successfully added to your 
